Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Christopher W. Smith. (2022) Release of α-granule contents during platelet activation. Platelets 33:4, pages 491-502.
Read now
Read now
Tibor Szük, Zsolt Fejes, Ildikó Beke Debreceni, Adrienne Kerényi, István Édes, János Kappelmayer & Béla Nagy Jr. (2016) Integrity® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience® everolimus-eluting stents in stable angina patients. Platelets 27:5, pages 410-419.
Read now
Read now
Zsuzsa Simon, Andrea Kiss, Ferenc Erdödi, Hendra Setiadi, Ildikó Beke Debreceni, Béla Nagy$suffix/text()$suffix/text() & János Kappelmayer. (2010) Protein phosphatase inhibitor calyculin – A modulates activation markers in TRAP-stimulated human platelets. Platelets 21:7, pages 555-562.
Read now
Read now
Articles from other publishers (12)
Ádám Illési, Zsolt Fejes, Marianna Pócsi, Ildikó Beke Debreceni, Katalin Hodosi, Béla Nagy Jr., János Kappelmayer, Zsolt Kőszegi, Zoltán Csanádi & Tibor Szük. (2023) Technically Challenging Percutaneous Interventions of Chronic Total Occlusions Are Associated with Enhanced Platelet Activation. Journal of Clinical Medicine 12:21, pages 6829.
Crossref
Crossref
Ádám Illési, Ildikó Beke Debreceni, Zsolt Fejes, Béla NagyJrJr, Katalin Hodosi, János Kappelmayer, Zoltán Csanádi & Tibor István Szük. (2022) Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion. Thrombosis Research 217, pages 64-72.
Crossref
Crossref
Konstantinos Zifkos, Christophe Dubois & Katrin Schäfer. (2021) Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. International Journal of Molecular Sciences 22:17, pages 9317.
Crossref
Crossref
Meganathan Kannan, Firdos Ahmad & Renu Saxena. (2019) Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood Reviews 37, pages 100583.
Crossref
Crossref
Edoardo Elia, Fabrizio Montecucco, Piero Portincasa, Amirhossein Sahebkar, Hamid Mollazadeh & Federico Carbone. (2018) Update on pathological platelet activation in coronary thrombosis. Journal of Cellular Physiology 234:3, pages 2121-2133.
Crossref
Crossref
Zsolt Fejes, Zsolt Czimmerer, Tibor Szük, Szilárd Póliska, Attila Horváth, Enikő Balogh, Viktória Jeney, Judit Váradi, Ferenc Fenyvesi, György Balla, István Édes, József Balla, János Kappelmayer & Béla Nagy. (2018) Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting. PLOS ONE 13:6, pages e0197890.
Crossref
Crossref
Justyna Rosińska, Maria Łukasik & Wojciech Kozubski. (2017) The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles. Cardiovascular Drugs and Therapy 31:5-6, pages 627-644.
Crossref
Crossref
Gergely Becs, Renáta Hudák, Zsolt Fejes, Ildikó Beke Debreceni, Harjit Pal Bhattoa, József Balla & János Kappelmayer. (2016) Haemodiafiltration elicits less platelet activation compared to haemodialysis. BMC Nephrology 17:1.
Crossref
Crossref
Zheng Wang, Zachary M. Emond, Megan E. Flynn, Suchitra Swaminathan & Melina R. Kibbe. (2016) Microparticle levels after arterial injury and NO therapy in diabetes. Journal of Surgical Research 200:2, pages 722-731.
Crossref
Crossref
Giancarla Scalone, Ilaria Coviello, Lucy Barone, Irma Battipaglia, Cristina Aurigemma, Giulia Careri, Gaetano Pinnacchio, Pierpaolo Tarzia, Gaetano Antonio Lanza & Filippo Crea. (2011) Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction. Thrombosis Research 128:2, pages 174-178.
Crossref
Crossref
Éva Csongrádi, Bela NagyJrJr, Tibor Fulop, Zsuzsa Varga, Zsolt Karányi, Mária Magyar, László Oláh, Mária Papp, Andrea Facskó, János Kappelmayer, György Paragh & Miklós Káplar. (2017) Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thrombosis and Haemostasis 106:10, pages 683-692.
Crossref
Crossref
E. SHANTSILA, P.W. KAMPHUISEN & G.Y.H. LIP. (2010) Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. Journal of Thrombosis and Haemostasis 8:11, pages 2358-2368.
Crossref
Crossref